Free Trial

Innate Pharma (IPHA) Earnings Date, Estimates & Call Transcripts

Innate Pharma logo
$1.42 -0.01 (-0.35%)
Closing price 03:59 PM Eastern
Extended Trading
$1.42 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Innate Pharma Earnings Summary

Innate Pharma announced Q4 2025 earnings on February 14, 2026, reporting an EPS of -$0.18. Quarterly revenue was reported to be $2.41 million. With a trailing EPS of $0.00, Innate Pharma's earnings are expected to grow next year, from ($0.55) to ($0.41) per share.

Q4 2025 Earnings Resources

IPHA Upcoming Earnings

Innate Pharma's Q1 2026 TU earnings is estimated for Wednesday, May 13, 2026, based on past reporting schedules, with a conference call scheduled at 9:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Upcoming Q1
Earnings Date
May. 13Before Market OpensEstimated
Actual Revenue
(Feb. 14)
$2.41M
Get Innate Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Innate Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Innate Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.14-$0.14-$0.14
Q2 20261-$0.08-$0.08-$0.08
Q3 20261-$0.15-$0.15-$0.15
Q4 20261-$0.12-$0.12-$0.12
FY 2026 4 -$0.49 -$0.49 -$0.49
Q1 20271-$0.15-$0.15-$0.15
Q2 20271-$0.15-$0.15-$0.15

Innate Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2026
(Estimated)
-------
2/14/2026Q4 2025--$0.18--$0.18-$2.41M

Data powered by Fiscal.ai.

Innate Pharma Earnings - Frequently Asked Questions

Innate Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 13th, 2026 based off last year's report dates. Learn more on IPHA's earnings history.

Innate Pharma (NASDAQ:IPHA) has a recorded annual revenue of $10.19 million.

Innate Pharma (NASDAQ:IPHA) has a recorded net income of -$55.64 million. IPHA has generated $0.00 earnings per share over the last four quarters.

Innate Pharma's earnings are expected to grow from ($0.55) per share to ($0.41) per share in the next year.


This page (NASDAQ:IPHA) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners